In severe cases, COVID-19 causes a patient’s immune system to go into overdrive. Termed the ‘cytokine storm,’ this creates hyperinflammation which wreaks havoc on the body. While therapies are currently limited, researchers at Lawson Health Research Institute are exploring novel treatments that could calm the cytokine storm and improve patient outcomes.
WORLDiscoveries, the technology transfer and business development office for Western University, Lawson Health Research Institute and Robarts Research Institute, recently announced the recipients of the 2020 Vanguard Awards.
Vanguard Awards recognize local researchers who, through partnership with WORLDiscoveries, have achieved various market-readiness milestones.
A new study from Lawson Health Research Institute, Western University and University of Alberta suggests that COVID-19 affects the human body’s blood concentration levels of specific metabolites – small molecules broken down in the human body through the process of metabolism. Three specific metabolites identified in this study could act as biomarkers and one day be measured through an inexpensive blood test to quickly screen patients for the disease and predict which patients will become most critically ill.